Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.

Jayaraman, Muralidharan; Radhakrishnan, Rangasudhagar; Mathews, Cara A; Yan, Mingda; Husain, Sanam; Moxley, Katherine M; Song, Yong Sang; Dhanasekaran, Danny N

Jayaraman, Muralidharan; Radhakrishnan, Rangasudhagar; Mathews, Cara A; Yan, Mingda; Husain, Sanam; Moxley, Katherine M; Song, Yong Sang; Dhanasekaran, Danny N.

Afiliação

Jayaraman M; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Radhakrishnan R; Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mathews CA; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Yan M; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Husain S; Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Moxley KM; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Song YS; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Dhanasekaran DN; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Genes Cancer ; 8(5-6): 566-576, 2017 May.

Article em En | MEDLINE | ID: mdl-28740575

Palavras-chave

Endometrial cancer; miR-142; miR-15a; miRNA; therapy response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Genes Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google